Oriola-KD Oyj - Company Announcement

Oriola-KD signed agreements with four pharmacy chains in Sweden on purchasing, warehousing and pharmacy distribution of OTC products and traded goods

Oriola-KD Corporation Stock Exchange Release 29 June 2012 at 4 p.m.


Oriola-KD's Swedish pharmaceutical wholesale business Oriola AB has today
signed, based on the letter of intent published on 9 May 2012, agreements with
Swedish pharmacy chains Apoteksgruppen, DocMorris, Medstop and Vårdapoteket.
Oriola AB provides Apoteksgruppen, DocMorris, Medstop and Vårdapoteket with new
and innovative service offerings for the purchasing, warehousing and pharmacy
distribution of OTC and traded goods products. The pharmacy chains had the
following market shares of the Swedish pharmacy market in 2011: Apoteksgruppen
10.8 %, Medstop 7.7 %, Vårdapoteket 4.4 % and DocMorris 2.4% (KPMG report
01/2012).

Purchases of the OTC and traded goods are expected to be some SEK 1 200 million
annually starting from 2013. The new services for the pharmacy chains will be
launched during the last quarter of 2012.


Oriola-KD Corporation


Eero Hautaniemi
President & CEO


For additional information, please contact:

Mr. Eero Hautaniemi
President & CEO
tel. +358 10 429 2109
email: eero.hautaniemi@oriola-kd.com


Mr. Joni Ihantola
VP, Treasury & IR
tel. +358 10 429 4386
email: joni.ihantola@oriola-kd.com

Distribution:
NASDAQ OMX Helsinki Ltd.
Principal media

Published by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo
www.oriola-kd.com


[HUG#1623116]